The impact of national guidelines on venom immunotherapy practice in the United Kingdom

Research output: Contribution to journalArticlepeer-review


  • P. Ewan
  • P.A.J. Huber
  • A. Clark
  • S. Nasser
  • M T Krishna

External organisations

  • Heartlands Hospital


Venom immunotherapy (VIT) is the only effective treatment for prevention of further anaphylactic reactions to bee and wasp stings in allergic individuals. A previous national survey carried out in 2006/2007 revealed significant heterogeneity in UK practice.The British Society for Allergy and Clinical Immunology (BSACI)
guidelines for the diagnosis and management of hymenoptera venom (HV) allergy were subsequently published in 2011.This repeat survey was carried out to assess whether publication of BSACI guidelines helped improve the diagnosis and management of HV allergy in the UK National Health Service (NHS).


Original languageEnglish
Pages (from-to)749-753
JournalClinical and Experimental Allergy
Issue number5
Early online date26 Apr 2016
Publication statusPublished - May 2016


  • Allergy and Immunology, Immunotherapy, Hymenoptera, Anaphylaxis, national guidelines